Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. The company aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.
Paradigm Health had 202 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Paradigm Health had 11,955 followers as of October 12, 2026. The number of followers increased by 64 (0.54%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 04, 2025 | Series B | $78.00M | ― |
| Investor Name | Funding Round |
|---|---|
| General Catalyst | Series B |
| Lux Capital | Series B |
| GV | Series B |
| F-Prime | Series B |
| ARCH Venture Partners | Series B |
| DFJ Growth | Series B |
| Mubadala Capital | Series B |
| American Cancer Society's BrightEdge Fund | Series B |
A snapshot of private companies similar to Paradigm Health, helping you discover and navigate related company profiles.



